Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on May 14, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Progenesis QI Software Acquisition

Closed
FDA-75F40126Q00143Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract seeks the acquisition of a single commercial perpetual license for Progenesis QI Software, along with associated activation credentials and commercial documentation, under a firm-fixed-price arrangement. This is a straightforward procurement of software with no additional services such as system development, hosting, contractor access to FDA systems, or ongoing support. The software must be delivered within 90 calendar days of contract award to the specified location in St. Louis, Missouri, and must fully conform to the Revised 508 Accessibility Standards, requiring the contractor to provide an Accessibility Conformance Report using the Voluntary Product Accessibility Template (VPAT). All submissions must be made electronically via email to the contracting officer, using macro-free Microsoft Office formats, and must include the offeror’s Unique Entity Identifier. The evaluation process follows a Lowest Price Technically Acceptable (LPTA) methodology, where proposals must meet all technical requirements to be considered, and award will be made to the lowest-priced technically acceptable offer without negotiations or clarifications. Pricing details are not provided in the solicitation, and no estimated contract value is available due to incomplete cost data in the line-item schedule. The contract incorporates a comprehensive set of federal regulations addressing cybersecurity, supply chain security, ethics, and employee rights, including prohibitions on software or services from Kaspersky Lab, ByteDance, Huawei, ZTE, Hikvision, Dahua, and other covered entities under the Federal Acquisition Supply Chain Security Act. Contractors must adhere to strict ethical standards, whistleblower protections, and equal opportunity requirements, and must ensure compliance with federal payment protocols through the Invoice Processing Platform (IPP), with no alternative invoicing methods permitted. Delivery and acceptance occur at the designated location, with the Government having up to ten business days to accept or reject the product, and the contractor given thirty days to remedy any deficiencies. No packaging, preservation, or marking specifications are required, and there are no key personnel or subcontracting plan obligations specified. While option periods are referenced under FAR 52.217-7, they remain unfunded at award and would require subsequent modifications should the Government choose to exercise them. All offerors must provide certification of Section 508 compliance and affirm that they do not use prohibited technologies, with noncompliance resulting in automatic disqualification.

General Info

Acquisition of Progenesis QI software license excluding development, hosting, or managed services.

Agency

Department Of Health And Human Services → FDA Office Of Acq Grant SvcsView Agency

NAICS

5132 - Software Publishers

Place of Performance

Saint Louis, MO, 63110, USA

Set-Aside

NONE

Documents

(1)

RFQ 75F40126Q00143 Progenesis QI Software Acquisition

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Combined Synopsis

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → FDA Office Of Acq Grant Svcs
Contacts1 person available
OfficeRockville, MD, 20852, USA
Organization / Agency
Department Of Health And Human Services → FDA Office Of Acq Grant Svcs
View Agency Profile
Office AddressRockville, MD, 20852, USA
Contacts
Roosevelt Walker

Full Description

Show more

Contractor shall provide one (1) commercial perpetual software license for Progenesis QI Software License. The scope includes delivery of the software, activation credentials, and applicable commercial documentation. This acquisition does not include system development, hosting services, contractor access to FDA systems, or ongoing managed services. 

More opportunities from Department Of Health And Human Services → FDA Office Of Acq Grant Svcs

Same awarding agency

NAICS: 541714
New
Federal
Human Hindbrain Organoid Functional Assay Services.
Solicitation # RFQ_CDR-2026-135968
The U.S. Food and Drug Administration, through the Center for Drug Evaluation and Research, intends to award a sole-source, firm-fixed-price purchase order to OrganoTherapeutics SARL for human iPSC-derived hindbrain organoid functional assay services. This acquisition, conducted under FAR Part 12 as a commercial service, aims to support in vitro research on drug-induced effects on respiratory-relevant neural circuits. The scope of work includes the provision of human hindbrain organoids and associated culture materials, with twelve scheduled deliveries to the FDA White Oak Campus in Silver Spring, Maryland. The first delivery will consist of 96 organoids, followed by eleven subsequent deliveries of 48 organoids each. The contractor will perform functional characterization at its own laboratory using three-dimensional multi-electrode array technology to assess electrophysiological responses to FDA-identified drug and reversal-agent combinations. Key deliverables include the raw and analyzed data, analysis files, and comprehensive study reports. The anticipated period of performance is 18 months from the date of award. Award will be based on best value, with technical capability and past performance weighted more heavily than price. All invoicing must be processed electronically through the U.S. Department of Treasury's Invoice Processing Platform.
Research and Development in Biotechnology (except Nanobiotechnology)

POSTED

about 15 hours ago

DEADLINE

in 5 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS